Beth A. Carter, MD

Beth Carter, MD

Section Chief, Hepatology
Medical Director, Liver Transplant Program
Professor of Clinical Pediatrics, Keck School of Medicine of USC

Dr Beth Carter is currently Clinical Professor of Pediatrics at Children’s Hospital Los Angeles/Keck USC School of Medicine. She joined CHLA in June 2018 as Medical Director of Intestinal Rehabilitation and Pediatric Liver Transplantation. Prior to CHLA, she served for 18 years as a Pediatric Transplant Hepatologist at Texas Children’s Hospital (Houston) as well as the founding Director of the Pediatric Intestinal Rehabilitation Program at Texas Children’s since 2007. She is board certified in both Pediatric Gastroenterology, Hepatology, and Nutrition as well as Pediatric Transplant Hepatology (Liver Transplant). Dr Carter’s longstanding research interests include both basic research in the molecular etiology of intestinal failure-associated liver disease (“IFALD”) as well as clinical IRB-approved trials/studies in various intravenous lipid emulsions used in pediatric short bowel syndrome (SBS). Dr Carter has served as Primary Investigator or Co-Investigator in all of the Pediatric teduglutide/GATTEX® SBS clinical trials to date across 2 centers—previously Texas Children’s and, more recently, as part of her role at Children’s Hospital Los Angeles. She is currently serving as CHLA Primary Investigator on the NIH-sponsored clinical trial for Pediatric Acute Liver Failure "TReatment for ImmUne Mediated PathopHysiology (TRIUMPH). A Phase 2b, Double-Blind, Three Arm, Randomize, Placebo Controlled Trial with Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatrics."

Clinical Interests

Short Bowel
Syndrome Intestinal Rehabilitation
TPN (Total Parenteral Nutrition)
Hepatology Liver Transplant


Medical School

Feinberg School of Medicine/Northwestern University


CHOC Children's, General Pediatric


CHOC Children's, General Pediatrics Residency


Baylor College of Medicine/Texas Childrens Hospital, Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship



Liver Transplant, American Board of Internal Medicine
Pediatric Gastroenterology, American Board of Pediatrics

Professional Memberships

NASPGHAN (North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition)
ASPEN (American Society of Parenteral and Enteral Nutrition)


Safety Findings in Pediatric Patients During Long‐Term Treatment With Teduglutide for Short‐Bowel Syndrome–Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies S Hill, BA Carter, V Cohran, S Horslen, SS Kaufman, SA Kocoshis, ... Journal of Parenteral and Enteral Nutrition 45 (7), 1456-1465 4 2021

The pediatric solid organ transplant experience with COVID‐19: an initial multi‐center, multi‐organ case series MB Goss, NTN Galván, W Ruan, FM Munoz, ED Brewer, CA O’Mahony, ... Pediatric transplantation 25 (3), e13868 35 2021

579. Prophylactic Antibiotics Did Not Decrease Recurrent Cholangitis in Patients with Biliary Atresia After Kasai Portoenterostomy TM Tarro, L Song, BA Carter, M Yeh, PS Pannaraj, S Mohandas Open Forum Infectious Diseases 7 (Supplement_1), S354-S355 1 2020

Google Scholar link


Intestinal Rehabilitation 
Liver Transplant
Pediatric Acute Liver Failure
Short Bowel Syndrome 
TPN (Total Parenteral Nutrition)